chr5-177600404-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_007255.3(B4GALT7):c.50+144T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0986 in 600,386 control chromosomes in the GnomAD database, including 4,340 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.095 ( 1094 hom., cov: 31)
Exomes 𝑓: 0.10 ( 3246 hom. )
Consequence
B4GALT7
NM_007255.3 intron
NM_007255.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.441
Publications
1 publications found
Genes affected
B4GALT7 (HGNC:930): (beta-1,4-galactosyltransferase 7) This gene is a member of the beta-1,4-galactosyltransferase (beta4GalT) family. Family members encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose. Each beta4GalT member has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus which then remains uncleaved to function as a transmembrane anchor. The enzyme encoded by this gene attaches the first galactose in the common carbohydrate-protein linkage (GlcA-beta1,3-Gal-beta1,3-Gal-beta1,4-Xyl-beta1-O-Ser) found in proteoglycans. This enzyme differs from other beta4GalTs because it lacks the conserved Cys residues found in beta4GalT1-beta4GalT6 and it is located in cis-Golgi instead of trans-Golgi. Mutations in this gene have been associated with the progeroid form of Ehlers-Danlos syndrome. [provided by RefSeq, Oct 2009]
B4GALT7 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, spondylodysplastic type, 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
- Ehlers-Danlos syndrome, spondylodysplastic typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-177600404-T-C is Benign according to our data. Variant chr5-177600404-T-C is described in ClinVar as [Benign]. Clinvar id is 1246191.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B4GALT7 | NM_007255.3 | c.50+144T>C | intron_variant | Intron 1 of 5 | ENST00000029410.10 | NP_009186.1 | ||
B4GALT7 | XM_047416680.1 | c.-2082T>C | 5_prime_UTR_variant | Exon 1 of 6 | XP_047272636.1 | |||
B4GALT7 | XM_047416681.1 | c.-1061+144T>C | intron_variant | Intron 1 of 6 | XP_047272637.1 | |||
B4GALT7 | XM_047416682.1 | c.-346+144T>C | intron_variant | Intron 1 of 6 | XP_047272638.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0949 AC: 14424AN: 151974Hom.: 1091 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14424
AN:
151974
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0999 AC: 44796AN: 448294Hom.: 3246 AF XY: 0.100 AC XY: 22160AN XY: 221702 show subpopulations
GnomAD4 exome
AF:
AC:
44796
AN:
448294
Hom.:
AF XY:
AC XY:
22160
AN XY:
221702
show subpopulations
African (AFR)
AF:
AC:
240
AN:
10364
American (AMR)
AF:
AC:
1232
AN:
6866
Ashkenazi Jewish (ASJ)
AF:
AC:
2356
AN:
9378
East Asian (EAS)
AF:
AC:
7175
AN:
22272
South Asian (SAS)
AF:
AC:
925
AN:
9154
European-Finnish (FIN)
AF:
AC:
2344
AN:
19962
Middle Eastern (MID)
AF:
AC:
341
AN:
1882
European-Non Finnish (NFE)
AF:
AC:
27553
AN:
346702
Other (OTH)
AF:
AC:
2630
AN:
21714
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1838
3676
5515
7353
9191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0949 AC: 14432AN: 152092Hom.: 1094 Cov.: 31 AF XY: 0.0997 AC XY: 7409AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
14432
AN:
152092
Hom.:
Cov.:
31
AF XY:
AC XY:
7409
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
980
AN:
41546
American (AMR)
AF:
AC:
2948
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
919
AN:
3466
East Asian (EAS)
AF:
AC:
1565
AN:
5096
South Asian (SAS)
AF:
AC:
564
AN:
4808
European-Finnish (FIN)
AF:
AC:
1184
AN:
10590
Middle Eastern (MID)
AF:
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5868
AN:
68000
Other (OTH)
AF:
AC:
265
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
639
1278
1916
2555
3194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
828
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.